IV Ciprofloxacin and Metronidazole Dosing
Standard Adult Dosing
For IV ciprofloxacin, administer 400 mg every 8–12 hours depending on infection severity, and for IV metronidazole, give a 15 mg/kg loading dose followed by 7.5 mg/kg every 6 hours (approximately 500 mg for a 70-kg adult). 1, 2
IV Ciprofloxacin Dosing by Indication
- Intra-abdominal infections (complicated): 400 mg IV every 12 hours for 7–14 days, used in conjunction with metronidazole 1
- Severe/complicated infections (lower respiratory tract, skin/skin structure): 400 mg IV every 8 hours for 7–14 days 1
- Nosocomial pneumonia: 400 mg IV every 8 hours for 10–14 days 1
- Mild/moderate infections: 400 mg IV every 12 hours 1
- Infusion duration: Administer over 60 minutes to minimize venous irritation 1
IV Metronidazole Dosing
- Loading dose: 15 mg/kg infused over 1 hour (approximately 1 g for a 70-kg adult) 2
- Maintenance dose: 7.5 mg/kg infused over 1 hour every 6 hours (approximately 500 mg for a 70-kg adult), starting 6 hours after the loading dose 2
- Surgical prophylaxis: 15 mg/kg over 30–60 minutes completed 1 hour before surgery, followed by 7.5 mg/kg at 6 and 12 hours post-initial dose 2
- Maximum daily dose: Do not exceed 4 g in 24 hours 2
- Usual duration: 7–10 days for most anaerobic infections 2
Ciprofloxacin Dose Adjustment in Renal Impairment
Dose reduction is mandatory when creatinine clearance falls below 30 mL/min. 1
Renal Dosing Algorithm
| Creatinine Clearance | IV Ciprofloxacin Dose | Frequency |
|---|---|---|
| >30 mL/min | 400 mg | Every 8–12 hours (per indication) [1] |
| 5–29 mL/min | 200–400 mg | Every 18–24 hours [1] |
- For patients with CrCl 31–60 mL/min, 400 mg every 12 hours provides plasma concentrations equivalent to those in patients with CrCl 61–90 mL/min receiving 400 mg every 8 hours 3
- For patients with CrCl ≤30 mL/min, modeling suggests 400 mg every 24 hours achieves adequate concentrations 3
- Important caveat: One study found that dosage reduction may not be required in renally impaired patients unless they have co-existent intra-abdominal disease, in which case significantly higher serum concentrations occur and dose reduction becomes necessary 4
Calculating Creatinine Clearance
When only serum creatinine is available 1:
- Men: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
- Women: 0.85 × male calculation
Metronidazole Dose Adjustment in Hepatic and Renal Impairment
- Severe hepatic disease: Administer doses below usual recommendations with close monitoring of plasma levels, as metronidazole accumulates in hepatic dysfunction 2
- Anuric patients: No specific dose reduction required, as metabolites are rapidly removed by dialysis 2
- Elderly patients: Pharmacokinetics may be altered; monitor serum levels to adjust dosing 2
Critical Considerations for Combination Therapy
- Ciprofloxacin + metronidazole is specifically recommended for complicated intra-abdominal infections to cover both aerobic gram-negatives and anaerobes 1
- Pharmacokinetic studies confirm no significant drug interactions between IV ciprofloxacin and metronidazole when co-administered 5
- Do not mix ciprofloxacin with other drugs in the same IV line; if using a primary IV system, discontinue it during ciprofloxacin infusion 2
- Metronidazole should be administered by slow IV drip infusion only; do not introduce additives into the solution 2
Dosing Pitfalls in Critically Ill Patients
- Standard doses may be inadequate in critically ill patients with augmented renal clearance or infections caused by less susceptible pathogens (MIC ≥0.5 mg/L): Doses up to 600 mg four times daily may be required to achieve pharmacodynamic targets (AUC/MIC >125) 6
- For patients with eGFR >100 mL/min and pathogens with MIC ≥0.5 mg/L, standard dosing will likely fail to achieve adequate target attainment 6
- Conversely, in impaired renal function with less susceptible pathogens, even 400 mg daily may be insufficient 6